COMP <GO>
NXTS vs EVGN // EV/EBITDA & P/E VALUATION
Nexentis Technologies Inc. (NASDAQ) VS. Evogene Ltd (NASDAQ) • 15-METRIC TALLY: NXTS 0
— EVGN 2
■ METRIC PARITY
LAST: $0.63 (+0.40%) • MKT CAP: $1.9M
valuation
—
LAST: $0.38 (+1.60%) • MKT CAP: $6.0M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NXTS VS. EVGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NXTS | EVGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -27.40% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 27.4 | 41.5 | -14.16 | EVGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.9M | $6.0M | -$4.1M | EVGN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NXTS REV | EVGN REV | NXTS GROSS % | EVGN GROSS % | NXTS FCF | EVGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | — | — | — | -$3.8M | — |
| FY 2024 | $210.0K | — | 21.4% | — | -$3.4M | — |
| FY 2023 | $263.0K | — | — | — | -$3.2M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NXTS // BETA —
EVGN // BETA —